Why Tc-99m Sestamibi Scan is Performed After CT Shows Four-Gland Involvement
A Tc-99m sestamibi scan is performed after CT identifies nodules in all four parathyroid glands to distinguish between multi-glandular hyperplasia versus multiple adenomas, and to identify which glands are hyperfunctioning—critical information that fundamentally changes the surgical approach from targeted resection to bilateral neck exploration. 1
The Core Problem: Anatomic vs. Functional Imaging
CT provides anatomic information showing nodules in all four glands, but cannot determine which glands are actually hyperfunctioning and causing the hyperparathyroidism. The Tc-99m sestamibi scan provides functional imaging that identifies metabolically active, hyperfunctioning parathyroid tissue based on differential tracer uptake and washout characteristics 2, 3.
Why This Matters for Your Patient
When CT shows all four glands are enlarged, you're facing one of two scenarios:
- Four-gland hyperplasia (secondary or tertiary hyperparathyroidism): Requires subtotal parathyroidectomy or total parathyroidectomy with autotransplantation
- Multiple adenomas (less common): May allow more selective resection
The sestamibi scan helps differentiate these by showing uptake patterns. In hyperplasia, you typically see uptake in multiple glands with similar intensity. In multiple adenomas, uptake may be more focal and asymmetric 4, 5.
The Neuromuscular Connection
The significant lower leg neuromuscular symptoms suggest severe, longstanding hyperparathyroidism with potential:
- Hypercalcemic myopathy
- Proximal muscle weakness
- Possible secondary hyperparathyroidism from chronic kidney disease (which commonly presents with four-gland hyperplasia)
This clinical context makes accurate preoperative localization even more critical because these patients need definitive surgical cure to prevent progressive morbidity 1.
The Surgical Decision Tree
The imaging sequence directly determines surgical approach:
If sestamibi shows single focal uptake despite CT showing four nodules: Consider targeted parathyroidectomy with intraoperative PTH monitoring 1
If sestamibi confirms uptake in multiple/all glands: Proceed directly to bilateral neck exploration with subtotal or total parathyroidectomy 1
If sestamibi is negative or discordant with CT: Consider 18F-choline PET-CT as next step, or proceed to bilateral exploration by experienced surgeon 1
Key Technical Points
The dual-phase sestamibi protocol (early at 10-20 minutes, delayed at 2-3 hours) exploits the differential washout between thyroid tissue and hyperfunctioning parathyroid tissue 3, 6. Parathyroid adenomas retain tracer longer than normal thyroid, creating the characteristic "hot spot" on delayed imaging.
Sensitivity varies by pathology: Sestamibi detects 82% of single adenomas but only 31% of individual glands in multi-glandular disease 5. This is why the combination of CT (showing all four glands anatomically) plus sestamibi (showing functional activity) provides complementary information 2, 1.
Common Pitfalls to Avoid
Don't assume all four enlarged glands on CT means all four are hyperfunctioning: Some may be incidental thyroid nodules or reactive changes 2
Don't skip functional imaging in multi-glandular disease: Even when bilateral exploration is planned, knowing which glands are most active helps guide intraoperative decisions 1
Consider secondary/tertiary hyperparathyroidism: Four-gland involvement with neuromuscular symptoms raises suspicion for chronic kidney disease-related hyperparathyroidism, which has different management implications 2, 1
The Bottom Line
Imaging has no role in diagnosing hyperparathyroidism (that's biochemical), but is essential for surgical planning 2. When CT shows four-gland involvement, sestamibi functional imaging is the critical next step to determine whether you're dealing with hyperplasia requiring bilateral exploration versus potentially resectable adenomas. The combination guides the surgeon toward the correct operation the first time—crucial because reoperative parathyroid surgery has lower cure rates and higher complication rates 2, 1.
For your patient with neuromuscular symptoms, this accurate preoperative mapping is essential to achieve eucalcemia and reverse the progressive morbidity from severe hyperparathyroidism 1, 4.